The Ulutas Medical Journal · ISSN 2149-0430 (print), 2149-388X (online) · https://www.ulutasmedicaljournal.com/?mno=189685
Original Research · Open access
Determining Hepatitis C virus genotype distribution of Amasya area
Also available in: العربية · Türkçe · 中文
- Clinical Microbiology, Amasya University Research Hospital, Amasya, Turkey ROR
- Vocational School of Health Services, Amasya University, Amasya, Turkey ROR
- Gastroenterology, Amasya University Research Hospital, Amasya, Turkey ROR
- Internal Diseases, Amasya University Research Hospital, Amasya, Turkey ROR
- Medical Biochemistry, Kadirli State Hospital, Osmaniye, Turkey ROR
Abstract
Hepatitis C virus (HCV) is one of the most common reasons for liver carcinoma, cirrhosis and chronic liver deficiency worldwide. Knowing the genotype of HCV with many genotypes before the treatment would be clinically useful in organizing the treatment and follow-up. Retrospective investigation of HCV genotypes in chronic hepatitis C patients applying to our hospital was aimed in our study. Results of 82 chronic hepatitis C patients sent to Amasya University Sabuncuoglu Serefeddin Education and Research Hospital Microbiology Laboratory between 2010-2014 with positive anti-HCV and HCV-RNA were included in our study. Viral genotyping was made using Qiagen one-step RT-PCR (Qiagen, Hilden, Germany) and ABI PRISM 3730 (Perkin Elmer, USA) systems in order using real-time polymerase chain reaction (Rt-PCR) method. 79 (96.34%) of the patients were genotype 1, 2 (2.42%) were genotype 2 and 1 was (1.21%) genotype 3. The most common sub-types were found genotype 1b (69.51%) and genotype 1a (20.73%) in order. HCV genotype 1 (96.34%) is seen in high ratios in our area and the most common sub type is genotype 1b (69.51%).
Keywords
Full text
Introduction
Hepatitis C virus which is a shelled and single fibered RNA virus from Flaviviredae family is one of the most important reasons of hepatitis, cirrhosis and hepatocellular carcinoma. With number of people infected by HCV virus reaching 200 million and chronic acute infections reaching 80% constitute a serious threat (1, 2). In the studies made, the prevalence of this infection worldwide is 1-5% and this ratio is reported as 1-2,4% in our country, Turkey (3, 4).
Assessing the genotype of HCV which is known to have 6 major genotypes at least and over 80 sub-types is very important for organizing the treatment and follow-up (5, 6). While genotypes 1, 2 and 3 are common in the world, genotype 4 is common in Middle East and Egypt, genotype 5 is common in South Africa and genotype 6 is common in Far East. Genotype 1b with high resistance to the treatments is common in our country (7, 8). Retrospective evaluation of HCV genotype results in HCV-RNA positive blood samples of patients with HCV infections was aimed in our study.
Study Design
Genotype distribution of 82 patients which was sent to Microbiology Lab of Amasya University Education and Research Hospital between 2010-2014 with positive HCV-RNA were examined in our study. Viral genotyping was made using Qiagen one step RT-PCR (Qiagen, hilden, Germany) and ABI PRISM 3730 (Perkin Elmer, USA) systems in order using real-time polymerase chain reaction (Rt-PCR) method.
Results
Eighty two chronic hepatitis c patients consisting of 33 (40.24%) male and 49 (59.76%) female patients with positive anti-HCV and HCV rna were included in our study. Genotype information and epidemiological data of patients whose ages were between 23-77 and average age was 57.9 were evaluated retrospectively using hospital automation system and patient file information.
As the HCV genotype distributions of these patients were examined, 79 (96.34%) were genotype 1 (57 genotype 1b, 17 genotype 1a, 4 genotype1 and 1 genotype 1a/1b), 2 (2.44%) were genotype 2 (1 genotype 2a, 1 genotype 2b) and 1 (1.22%) was genotype 3. The types were not determined in 4 samples of genotype1. The most common sub types in the patients were found as 1b (69.51%) and 1a (20.73%) in order. The genotype distribution we obtained is shown in Table-1.
Discussion
There are many factors affecting the chronicalization of the infection in HCV infected people and prognosis of this chronicalized infection. The main among these factors are use of alcohol, gender of the patient, old age, genotype of the virus, co-infection with another hepatitis virus and viral load amount. The main factor which determines the medicine dose containing peg-interferon and ribavirin combination to be used during the treatment and treatment application period is genotype of HCV (9–12). Although the treatment duration in infections caused by HCV genotype 1 and 4 is longer than infections caused by genotype 2 and 3, the medicine dose is also higher. The positive response to the treatment is higher in infections caused by genotype 2 and 3. (11)We were concerned about the fact that HCV genotype 1 (96.34) which is more resistant to the treatment was in higher ratios in the study in our area than similar studies in our country. Isolation prevalence of genotype 1 in hcv infected patients in studies in different areas was found 93.3% in İzmir area(13), 92.8% in Trabzon area (14), 83.4% in Antalya area (15) and 62.4% in Kayseri area (16).
In recent studies in our country, it was observed that the dominant HCV genotype was 1b. Isolation prevalence of 1b genotype isolated from HCV infected patients was found 57.6% in Kayseri area (16), 63.3% in Antalya area (15) %63.3, 80.2% in İzmir area (13) and 84.7% in Mersin area (17). The result of our study was 69.51% which was in line with previous similar recent studies in our country. The most common sub type after genotype 1b was genotype 1a (20.73%). Although genotype 1a was the second in prevalence in Antalya (15) (14.7%), Trabzon (14) (5.3%) and İzmir (13) (12.9%) areas similar to our study, genotype 4 was isolated as the second in Kayseri area (16) (32%).
Genotype 2 (1.22%) and genotype 3 (1.22%) which are seen different from genotype 1 (96.34) which is common in our area were observed rarely. It was stated that the spreading of HCV genotypes between different areas may be caused by migration or travelling.(18) It was considered that the genotype variety other than genotype 1 which is the prevalent type in our area and low rates of other genotypes can be related to the fact that our area does not take immigrants.
Conclusion
As a result the most commonly isolated genotype in patients infected with hcv in our study which reflects the hcv genotype distribution in our area was genotype 1b (69.51%) and the fact that genotype 1, the infections of which show a worse prognosis, has a higher prevalence in our area (96.34%) made us worry. Also the fact that nearly all of the genotypes isolated were genotype 1 made us question the cost-efficiency situation. As using different molecular methods and the low number of patients in our study prevented objective results, covering many areas and using standard methods would be more useful.
Declarations
- Author contributions (CRediT)
- All authors contributed equally to all 14 CRediT roles (Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing).
- Funding
-
Funding information was not reported in the published version of this article.
- Conflicts of interest
- The authors declare that no conflict of interest exists in publishing this article.
- Ethics approval
- Ethics approval details were not reported in the published version of this article.
- Data availability
- A data availability statement was not reported in the published version of this article.
References (18)
11 of 18 references are linked to their DOI.
- Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alpha- 2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-65. Çetin KILINÇ et al. Hepatitis C Virus Genotype in Amasya Area DOI Crossref PubMed Google Scholar
- Koff RS. Hepatitis C. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. 3rd ed. Philadelphia: Lippincott Williams, 2004: 779-784. PubMed Google Scholar
- Nurdan Tozun, Osman C. Ozdogan, Yilmaz Cakaloglu, Ramazan Idilman, Zeki Karasu, Ulus S. Akarca,et al. A Nationwide prevalence study and risk factors for hepatitis A, B, C and D infections in Turkey. Hepatology. 2010; 52(1); 697. PubMed Google Scholar
- Dincer D. Hepatit C Epidemiyolojisi ve Patogenezi. Turkiye Klinikleri Gastroenterohepatol Topics. 2010; 3(1): 77-80. PubMed Google Scholar
- Nakano I, Fukuda Y, Katano Y, et al. Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype. Gut 2001; 49: 263-7. DOI Crossref PubMed Google Scholar
- Ural O, Arslan U, Fındık D. Konya bölgesinde hepatit C virusu genotip dağılımı. İnfeksiyon Derg 2007; 21: 175-81. PubMed Google Scholar
- Türkoğlu S. Hepatit C virüsü: Viroloji ve seroloji. Viral Hepatit 2003. Viral Hepatitle Savaş›m Derneği 2003; 186-98. PubMed Google Scholar
- Gökahmetoðlu S, Bozdayý M, Özbakýr Ö, et al. Hepatitis C virus genotypes detected in Erciyes University. Türk Mikrobiyoloji Cemiyeti Dergisi 2007;37(1): 35.38. DOI Crossref PubMed Google Scholar
- Thomas DL, Lemon SM. Hepatitis C. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases, 5th ed. Philadelphia: Churchill Livingstone Determination of hepatitis C virus genotype; 2000: p.1736.1760. PubMed Google Scholar
- Sherlock S, Dooley J. Hepatitis C Virus. Diseases of the Liver and Biliary System. 11th edition 2002; 305-316. DOI Crossref PubMed Google Scholar
- Jimenez-Mendez R, Uribe-Salas F, López-Guillen P, Cisneros-Garza L, Castañeda-Hernandez G. Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico. Ann Hepatol 2010; 9(1): 33-9. DOI Crossref PubMed Google Scholar
- Ramalho F, Costa A, Pires A et al: Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C. Dig Dis Sci 2000,45:182-187. DOI Crossref PubMed Google Scholar
- Altuğlu I, Sertöz R, Aksoy A, Gürsel D, Tüzüner U, Günşar F. Possible transmission risks and genotype distribution of hepatitis C virus infection in Western Turkey. Turk J Gastroenterol 2013; 24(5): 349-55. DOI Crossref PubMed Google Scholar
- Buruk CK, Bayramoğlu G, Reis A, Kaklıkkaya N, Tosun I, Aydın F. Determination of hepatitis C virus genotypes among hepatitis C patients in Eastern Black Sea region, Turkey. Mikrobiyol Bul 2013; 47(4): 650-7. DOI Crossref PubMed Google Scholar
- Sağlık İ, Mutlu D, Öngüt G, İnan D, Öğünç D, Distribution of Hepatitis C Virus Genotypes among Patients with Chronic Hepatitis C Infection in Akdeniz University Hospital, Antalya, Turkey: A Five-Year Evaluation Mikrobiyol Bul 2014; 48(3): 429-437 DOI Crossref PubMed Google Scholar
- Kayman T, Karakükçü Ç, Karaman A, Gözütok F. Kayseri bölgesinde hepatit C virus enfeksiyonunun genotip dağılımı.Türk Mikrobiyol Cem Derg 2012; 42(1): 21-6. PubMed Google Scholar
- Tezcan S, Ulger M, Aslan G, et al. Determination of hepatitis C virus genotype distribution in Mersin province, Turkey. Mikrobiyol Bul 2013; 47(2): 332-8. DOI Crossref PubMed Google Scholar
- Noorali S, Pace DG, Bagasra O. Of lives and livers: emerging responses to the hepatitis C virus. J Infect Dev Ctries 2011; 5(1): 1-17. DOI Crossref PubMed Google Scholar
Respond to this article
Comments on a published article are welcome as a Letter to the Editor.
Get an e-mail when new articles in your fields are published
Questions to the authors
Questions are moderated: an editor approves each question, the authors answer, and an editor approves the answer before both appear here.
No answered questions yet.
Ask the authors a question
Discussion
Comments are moderated: they appear after the writer confirms the e-mail address and an editor approves them. Each comment carries a conflict-of-interest statement.
No comments yet.
Write a comment
Tell me when this article is cited
Leave your e-mail address and confirm it. These notices are not being sent yet; your confirmed address is kept for them and used for nothing else.
Read the full text
Open the PDF here
Loading the PDF…
If the PDF does not show here, use the download button above.
How to cite this article
Kilinc C, Guckan R, Idil O, Guleryuzlu Y, Capraz M, Ulutas KT. Determining Hepatitis C virus genotype distribution of Amasya area. Ulutas Med J. 2015;1(2):41-43. doi:10.5455/umj.20150528125725
Kilinc, C., Guckan, R., Idil, O., Guleryuzlu, Y., Capraz, M., & Ulutas, K. T. (2015). Determining Hepatitis C virus genotype distribution of Amasya area. The Ulutas Medical Journal, 1(2), 41–43. https://doi.org/10.5455/umj.20150528125725
Kilinc, C. et al. (2015) 'Determining Hepatitis C virus genotype distribution of Amasya area', The Ulutas Medical Journal, 1(2), pp. 41–43. doi: 10.5455/umj.20150528125725.
@article{umj189685,
title = {Determining Hepatitis C virus genotype distribution of Amasya area},
author = {Kilinc, Cetin and Guckan, Ridvan and Idil, Onder and Guleryuzlu, Yuksel and Capraz, Mustafa and Ulutas, Kemal Turker},
journal = {The Ulutas Medical Journal},
year = {2015},
volume = {1},
number = {2},
pages = {41--43},
doi = {10.5455/umj.20150528125725},
url = {https://www.ulutasmedicaljournal.com/?mno=189685},
issn = {2149-388X}
}
